Clinical Roundup Computational biology tool automates and standardizes genome sequencing analysis, Sanford Burnham study finds March 20, 2026Vol.52 No.11
Clinical Roundup Inocras and Broad Institute researchers will release insights from TCGA cancer whole-genome analysis at AACR annual meeting March 20, 2026Vol.52 No.11
Drugs & Targets PanTracer LBx liquid biopsy profiling test receives Medicare coverage March 20, 2026Vol.52 No.11
Drugs & Targets Sartorius launches platform to boost efficiency in cell therapy production March 20, 2026Vol.52 No.11
Drugs & Targets START, Trialing collaborate to expand access to oncology clinical trials across Europe March 20, 2026Vol.52 No.11
Regulatory News Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again) March 13, 2026Vol.52 No.10By Claire Marie Porter
Regulatory News Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncologyAtara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.” March 13, 2026Vol.52 No.10By Jacquelyn Cobb
Guest Editorial As more people are surviving cancer, we must continue funding bold science March 13, 2026Vol.52 No.10By Karen E. Knudsen
Cancer Policy HHS postpones third USPSTF meeting in a row March 13, 2026Vol.52 No.10By Sara Willa Ernst
Cancer Policy FDA approves leucovorin for cerebral folate deficiency March 13, 2026Vol.52 No.10By Claire Marie Porter
